15:15 Dec 26
Bal Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Bal Pharma Ltd.
77/100 High Financial Strength
Quality68/100 Affordable Valuation
Valuation53/100 Technically Neutral
TechnicalSWOT
Strength
8
Weakness
4
Opportunity
0
Threat
0
192.64
Market Cap (Cr)
25.14
PE Ratio
2.80
Price to Book Ratio
45.02
RSI
2.17 %
Net Profit Margin
SWOT
Download Our App On:
